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FESS is nowadays the gold standard surgical treatment for chronic rhinosinusitis not responding to medical treatment.
The principal aim behind this surgical procedure was the maximum preservation of the nasal mucosal integrity, while
providing optimal disease clearance. One of the recent technical developments in endoscopic sinus surgery is balloon
sinuplasty.
Balloon sinuplasty is described as a less invasive technique to open the paranasal sinus ostias without injuring the
surrounding mucosa, which results in reduced intraoperative bleeding and minimal mucosal damage. The objective of this
work is to provide an overview of the procedure and to explain the surgical technique and its indications and limitations
and to discuss the results through articles published so far about the subject. Most of the studies show that this surgical
procedure is safe, feasible, and effective in selected patients and its advantages include that it is a daily surgery
(outpatient basis, can be done under L.A), low time off work, rapid recovery time and it does not limit further treatment
options.
Keywords: Functional endoscopic sinus surgery (FESS), balloon sinuplasty, rhinosinusitis.

INTRODUCTION
Chronic rhinosinusitis (CRS) affects approximately 30
million Americans annually.(1)
Functional endoscopic sinus surgery is recommended for
patients with chronic rhinosinusitis who have failed
maximum medical therapy, including appropriate
antibiotics, saline irrigation, nasal steroids, antihistamines
and allergy therapy.(2) The surgical management of
sinusitis was revolutionized worldwide with the advent of
the rigid Hopkins rod nasal endoscopes three decades
ago.(3) FESS is nowadays the gold standard surgical
treatment for chronic rhinosinusitis not responding to
medical treatment, the principal aim behind this surgical
procedure was the maximum preservation of the nasal
mucosal integrity, while providing optimal disease
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clearance. One of the recent technical developments in
endoscopic sinus surgery is balloon sinuplasty.
Engineers from California in 2002, started applying the
technique of balloon dilatation,(4) an established procedure
in cardiology, to dilate the ostium of the paranasal
sinuses. In 2005, this new technology was approved for
use In the United States by the Food and Drug
Administration (FDA) as a minimally invasive treatment
alternative for the chronic rhinosinusitis.
The manufacturers advocate the ENT surgeons to undergo
a 1-day training course with hands on cadaver work
before starting practicing the procedure on patients
because this procedure use a new surgical techniques and
use of fluoroscopy which many ENT surgeons unfamiliar
with. Balloon sinuplasty is described as a less invasive
technique to open the paranasal sinus ostias without
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injuring the surrounding mucosa, which results in
reduced intraoperative bleeding and minimal mucosal
damage.(5)
This FDA approved balloon sinus dilatational system is
used to widen the natural ostia of the paranasal sinuses
with endoscopic assistance and fluoroscopic C-arm
guidance.(3) Its advantages include that it is a daily surgery
(outpatient basis, can be done under L.A), low time off
work, rapid recovery time and it does not limit further
treatment options.
The objective of this work is to provide an overview of the
procedure and to explain the surgical technique and its
indications and limitations and to discuss the results
through articles published so far about this new surgical
procedure.

SURGICAL TECHNIQUE
The procedure is carried out under partial endoscopic
viewing and may be made with local or general
anesthesia. Rigid endoscopes of 0o, 30o and 45o are used
in the procedure. In addition to the catheters with balloons
(Fig. 1), there are guide catheters with several angulations
(Fig. 2), required to lead the catheters with balloon to the
margins of the region to be dilated. The set also includes

catheters for sinus lavage and a device coupled to a
monometer (Fig. 3) used to inflate the balloons. The
balloons are inflated with an iodized contrast diluted in
water or sterile saline, in an approximate concentration of
150-180mg/ml. The contrast is used to enable the location
of the inflated balloon through fluoroscopy. Generally 6 to
8 ml of contrast are required to achieve the desired
pressures. The normal balloon has 5 mm, but there are
also with 3 to 7 mm. Generally pressures from 8 to 12/atm
are sufficient for dilation, and the maximum
recommended pressure is of 16 atm. Pressures above these
increase the risks, for instance, of Agger Nasi cell fracture
and of the terminal recess in cases of frontal recess
dilation.(6) Recently an optical fiber system used for
location of the sinus through dermametropathism. Under
endoscopic viewing, the guide-catheter is placed close to
the sinusal ostium. A guide thread is passed across the
guide-catheter, by fluoroscopy, through the sinus. The
balloon catheter is then passed on the guide thread
through the sinusal ostium region. After the correct
location of the balloon in the sinusal ostium by
fluoroscopy, the pressure inside the balloon is gradually
increased by the iodized contrast infusion. After dilation,
the balloon is gradually emptied and the catheter is
removed,(15) Steps in using these devices are shown in
(Fig. 4).

Fig 1. Catheters with ballons for sinusal dilatation of different sizes (Acclarent Inc., Melano Park, CA).
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Fig 2. Semi-flexible guide-catheters of several angulations (Acclarent Inc., Melano Park, CA).

Fig 3. Device to inflate balloon (Acclarent Inc., Melano Park, CA).
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To gain initial sinus access, the Sinus
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The Balloon Sinuplasty™ system is

Guide Catheter is introduced into the

smoothly over the Sinus Guidewire

removed, leaving the ostium open and

target

and positioned across the blocked

allowing the return of normal sinus

Sinus

ostium. It is gradually inflated to

drainage and function. There is little

Guidewire is introduced through the

gently restructure the blocked ostium.

to no disruption to mucosal lining.

sinus

visualization.

under
A

endoscopic

flexible

Sinus Guide Catheter and gently
advanced into the target sinus.
Fig 4. Balloon sinuplasty technique (Acclarent Inc., Melano Park, CA).

INDICATIONS
The indications for balloon sinus dilation (BSD) treatment
for sinus disease are the same as those for standard
functional endoscopic sinus surgery (FESS) (Table 1). Like
FESS, BSD is intended to allow as permanent as possible
access to and ventilation of obstructed sinuses, thereby
allowing normal function to resume and ongoing
maintenance therapies to be effective.
However, BSD by itself is appropriate for only a subset of
patients who qualify for FESS. Since BSD is used solely for
dilation of obstructed ostia, its use is limited to the frontal,
sphenoid, and maxillary (ie, extranasal) sinuses. BSD may
be considered the treatment of choice for limited or
moderate disease involving these sinuses. In patients with
significant ethmoid disease, BSD can be used as an adjunct
to standard ethmoidectomy. BSD is performed either
before or after ethmoidectomy, depending upon the
preference of the surgeon to preserve normal anatomy for
BSD landmark purposes.(7)
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The ideal patient for BSD would be that with a chronic or
acute
recurrent
rhinosinusitis
record,
without
improvement with the use of antibiotics, topical
corticosteroids and/or allergy management. The patients
studied in the first works presented with an altered
computerized tomography with a Lund-Mckay score of
(6) < 10 or 12.(6,8) In addition to its use in patients with
chronic rhinosinusitis, this system may also be a good
option in those patients at intensive care units, where
there is a suspicion of sinusal focus resulting in a febrile
picture.(6,9) As these patients are generally anticoagulated
and in a critical clinical state, a minimally invasive
approach, with low risk of bleeding and short time
duration (by the anesthetic risk), would be an excellent
option.(10) After the ostium dilation, material collection for
culture, and sinus lavage are possible.(6,10) The sphenoidal
ostium, for example, may be easily dilated to an extent of
allowing access to a 4mm-endoscope.(6) Patients with
coagulopathy may also benefit from less bleeding risk.(9,10)
The use of balloon has other indications of great interest. It
may be an alternate for the Silent Sinus Syndrome, in
which the uncinectomy, in a fine uncinated and lateralized
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process, represents a risk of lesion of the orbitary
contents(9) Another possible indication would be its use in
combination with the functional surgery, especially in the

difficult review cases. The cannulation guided by
fluoroscopy and dermametropathism may be very helpful
in the frontal review surgeries.(6)

Table 1. Main indications and contraindications of the balloon sinuplasty.(6,9-11)
Main indications

Main contraindications

Chronic rhinosinusitis without improvement with clinical treatment

Significant ethmoidal disease

Recurrent acute rhinosinusitis

Presence of polyps

ICU febrile patients with sinusal focus

Mucocele

Frontal sinus recess treatment

Allergic fungal rhinosinusitis

Patients with high anesthetic risk

Osseous neoformation signs

Patients with bleeding risk

Cystic Fibrosis

Ciliary dysfunction

Nasosinusal Tumor

CONTRAINDICATIONS
Patients with pansinus polyposis, extensive fungal
disease, advanced connective tissue disease, or suspected
neoplasm should not be considered for BSD as the
principal modality (Table 1).
Opacification of a sinus by solid tissue inhibits view and
access with the Entellus device, and such disease cannot
be cleared with either the Entellus or the Acclarent device.
The surgeon must consider that the access to these sinuses
afforded by dilation of the native ostium would likely be
inadequate for extirpation of disease or for maintenance of
drainage postoperatively with topical treatment. BSD is
not appropriate for use in patients who require revision
surgery or in those with severe disease in which bony
thickening or dehiscence of the orbital wall or skull base
bone have occurred.(12,13)
No surgical treatment should be offered in the absence of
comprehensive medical treatment, including antibiotics,
steroids, nasal hygiene, and liberal use of topical nasal
therapies.

RESULT ANALYSIS
Brown CL et al(9) concomitant with ESS, they performed
balloon catheterization and dilatation of a total of 18
paranasal sinus ostia as follows: ten maxillary sinuses
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ostia, five sphenoid ostia, and three dilatation of the
frontal recess and concluded that no significant
complications were noted, trauma to the mucosa and
bleeding much less than that encountered in conventional
ESS.
Bolger et al(11) published the results of a prospective
multicenter analysis describing a 24-week post-balloon
sinuplasty follow-up with regards to complication rates,
patency of dilated ostia and post-operative patient
symptom outcome (Sino-nasal Outcome Test, SNOT 20),
In this follow-up period: Patency as determined by
endoscopic examination 80.5% (247/307) of cases, nonpatency 1.6% (5/307) of cases and Patency could not be
assessed endoscopically 17.9% (55/307) due to anatomical
problems ? but patency could still exist in these cases.(11)
SNOT 20 used for subjective evaluation by patients
showed continuously improved trend and revision
surgery was required in three sinuses 0.98% (3/307
sinuses) in three patients 2.75% (3/109 patients), no
serious adverse events reported (only 9 cases of bacterial
sinusitis treated with oral antibiotics). Devices
malfunctioned in 12 of 358 applications/sinuses, 7 cases:
balloon ruptured, 4 cases: the catheter tip malfunctioned, 1
case: balloon device deflated slowly. The median
fluoroscopy time per sinus was 0.81 minutes; the average
radiation dose per patient was approximately 730 mrem.

PAN Arab Journal of Rhinology

Al-Shagahin and Al-Hosban
FRIEDMAN et al(8) compared a group of patients treated
with balloon sinuplasty with a group submitted to
traditional FESS. A total of 70 adult patients were
evaluated. All patients were submitted to SNOT 20 test(14)
before and after the procedure. The results showed a
significant improvement in the SNOT 20 in both groups.
As for the patients satisfaction with the interventions;
91.4% answered “yes, for sinuplasty, against 48.6% of the
patients submitted to FESS. The number of days the
patients used analgesic medication was also significantly
lower in the patients submitted to sinuplasty (0.80 ± 0.72
days) against FESS patients (1.34 ± 0.99 days; p = 0.011).
The expenditures with sinuplasty were of approximately
US$ 12,656.57 ± 3,184.08 against US$ 14,471.14 ± 2,743.68
for FESS, and this difference is significant (p = 0.013). The
author confirms the sinuplasty and FESS were similar in
the postoperative symptoms improvement; however, the
sinuplasty obtained a better performance in the patient’s
satisfaction and in the postoperative pain.(15)
LEVINE HL et al(16) carried out a retrospective study of
patients submitted to nasosinusal endoscopic surgery with
the use of balloon dilation in 27 American services from
December 2005 through May 2007, including a total of
1036 patients. Out of whom, 855 (82.5%) had never been
submitted to sinusal surgery and 181 (17.5%) were
revisional. A total of 3276 sinuses were treated with
balloon dilation. These were followed-up on an average of
40.2 weeks after the procedure. No major adverse event
regarding the procedure was reported. The average
bleeding was of 77.5ml, and it was of 27.7ml in cases
where only balloon was used and 101.6ml in the cases
combined with FESS. A total of 2.4% of the patients
required revision due to the disease’s recurrence. They
represented 1.3% of the sinuses treated by balloon
dilation. As far as the symptoms are concerned, 95.5% of
the patients had an improvement. They concluded the
balloon dilation is safe, effective and improves the quality
of life of patients who didn’t have a response to the
clinical treatment. ICU patients who have a higher
anesthetic risk and present with isolated sphenoidal
disease may benefit from the use of balloons, since this
provides a fast treatment and with low bleeding risk.(6,9,10)
As for the frontal recess region, VAUGHAN WC(4) reports
this area surgery may lead to severe complications relating
to the cranial base, anterior ethmoidal artery, olfactory
mucosa and periorbitary tissues. This region is the one
which requires more review due to cicatricial stenosis. The
large removal of mucosa, edema, infection and incomplete
surgery also lead to the disease’s recurrence. One of the
main advantages relating to the use of balloon is its
potential to a minimally invasive treatment of the frontal
recess. The use of balloon combined to the endoscopic
surgical approach may minimize the surgical
complications relating to the frontal recess. REHL et al(17)
reviewed a series of patients in whom 136 frontal recesses
were treated with balloon dilation. Out of 95 recesses that
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could be reevaluated, 99% were patent. PAYNE SC et al(18)
reported the frontal recess dilation of 20 patients with
chronic rhinosinusitis. In a follow-up of 5 months, they
described the absence of complications and the significant
tomographic improvement in the Lund-Mackay score. As
for the risks, these seem to be low, in spite of the
possibility of noble structures lesion, such as the cranial
orbit and base. To avoid serious complications in these
structures, BOLGER et al(10) reported we should evaluate
the structures carefully as the cranial base for dehiscence
and also anatomic variations of the ethmoid roof, such as
KEROS’ ranking(19) type III for instance, therefore, the
analysis of the anatomic region of the frontal region on the
preoperative CT-scan for existing anatomic variations in
each patient is mandatory.(15) BROWN CL et al(9) also
mention the care we must take in patients with Keros type
III. They also recommend caution in patients with osseous
neoformation signs, because an attempt to dilate may not
be efficient and there’s the risk, in case we use an
exaggerated pressure, it is transmitted to adjacent
structures such as the cranial base and orbit. We must also
take a lot of care during the procedure to avoid
postoperative complications, such as the middle
infundibulum lateralization and its adherence with the
uncinate process.(6,8) LEVINE et al(16) reported 3 cases of
liquoric fistula in patients submitted to balloon dilation.
However they related these events to the functional
endoscopic surgery that was performed simultaneously to
dilation.
As for limitations of balloon sinuplasty in frontal sinus
surgery, Heimgartner et al(20) reported a multicenter study
investigated the aetiology of failed access to the frontal
sinus, the study analyzed retrospectively the charts of
patients who underwent balloon sinuplasty over three
years at three different ENT-centers. CT-analysis of the
patients with failed access was performed. Of the 104
frontal sinuses, dilatation of 12 (12%) sinuses failed, The
anatomy of all failed cases revealed variations in the
frontal recess (frontoethmoidal-cell, frontal-bulla-cell or
agger-nasi-cell) or osteoneogenesis, and they conclude that
in complex anatomical situations of the frontal recess,
balloon sinuplasty may be impossible and it is essential in
these situations to have knowledge of classical functional
endoscopic sinus surgery of the frontal recess area.
Ramadan et al(21) assess the surgical outcomes in children
undergoing sinus balloon catheter dilatation for whom
previous adenoidectomy has failed and conclude that
balloon dilatation is effective in children for whom
previous adenoidectomy has failed, and balloon dilatation
may be considered prior to proceeding to functional
endoscopic sinus surgery in children with chronic
rhinosinusitis.

71

Balloon Sinuplasty

DISCUSSION
The balloon sinuplasty technology uses a small, flexible,
balloon catheter to open up the blocked sinus ostium, by
inflation with a calibrated pressure gauge. When the sinus
balloon is inflated optimally, it gently restructures the
sinus ostium by inducing microfractures and bony
displacement around the occluded ostium, thus
circumferentially widening the walls of the ostium, while
maintaining the integrity of the sinus mucosal lining
around the ostium. The benefits of using the balloon
sinuplasty technology include, preservation of the normal
anatomy of the vital osteo-meatal complex, while
precisely focusing on the occluded sinus ostium and the
diseased sinus cavity beyond it.(10,22)
The safety of balloon dilatation technology has been well
established through large registries and cumulative
patients experience.(9,11) Although complications have
been described,(23) it also important to recognize and
define the limitations of balloon technology, for example,
current publications studied patients with milder
symptoms and or radiologic disease but the feasibility of
balloon dilatation in severe disease has not been well
studied or documented, the inability to remove tissue in
balloon only procedures is another potential limitation.
For disease such as maxillary sinus fungus ball, balloon
dilatation would be contraindicated as alone procedure, in
other situations, the lack of tissue removal in balloon-only
procedures may lead to a missed diagnosis of
neoplasm.(20) Efficacy has been demonstrated by technical
success of cannulating the sinus ostium and completion of
the balloon dilatation, the technique is largely successful,
with 80% to 97% rates of procedure completion in most
series.(9) Recent literature has documented clear
indications for the balloon sinuplasty surgery. Ideal
candidates for this procedure would include, chronic
sinusitis limited mostly to ostial obstruction of the frontal,
maxillary and sphenoidal sinuses, with near normal
middle meatal integrity. It has been deemed inappropriate
for patients with sino-nasal polyposis, isolated ethmoidal
disease, deformed osteomeatal anatomy or extensive
previous surgery with significant osteoneogenesis.(11,24)
Some Authors commented that not always possible to
canulate the frontal sinus as the anatomy sometimes
prevent the passage of the Guide Wire into the ostium of
the frontal sinus. Attachment of Uncinate process- type Aattached to the lateral nasal wall- Easy to cannulate , while
Type B-attached to the skull base or middle turbinatedifficult, you have to resect the UP, because of all of this,
BS should be done by expert in conventional FESS.(20)
Hence, careful case evaluation and selection remains
paramount in providing the best outcomes with this
technique.
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Church et al CA(25) and CHANDRA RK(26) demonstrated
the radiation dosages to which surgeons and patients are
exposed during fluoroscopy are very low, but we must
take care to minimize such exposure as much as possible.
CHANDRA RK(26) advises the surgeons to use specific
clothes, goggles and cervical protectors against radiation,
he also mentioned that the left eye of the patient is more
exposed to radiation, because the radiation source is
normally located on his left side.
Children who have persistent rhinosinusitis after
adenoidectomy are often treated with FESS. FESS has a
reliable profile in children, having a low complications
rate and a success rate of 75%-88%.(27) It is, however, an
invasive procedure, and serious complications can
occurred include hemorrhage, CSF leakage, and orbital
complications.(28)
Also, concerns regarding facial growth persist despite
negative findings in photographic and radiographic
studies in humans.(29) Balloon dilatation is effective in
children for whom previous adenoidectomy has failed,
and balloon dilatation may be considered prior to
proceeding to functional endoscopic sinus surgery in
children with chronic rhinosinusitis.(20)
What will be the future of Balloon Sinuplasty? Feasible,
safe in selected cases but re-usable catheter and balloon
will encourage further extend of its use (cost factor).
Possible further usage in rhinology in the future includes
fractures of anterior wall of frontal sinus,(29) recurrent
choanal atresia, etc.

FINAL COMMENTS
The Balloon Sinuplasty seems to be a feasible, safe and
well tolerated procedure, and in properly selected
patients, balloon dilatation appears to lead to clinical
improvement. It is also important to recognize and define
the limitations of balloon technology. Studies to confirm
its cost in the Middle East and Arab countries are still
necessary to evaluate its economic feasibility. The
feasibility of balloon dilatation in severe disease has not
been well studied or documented.
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